Erratum to: Pregnancy outcome among partners of male patients receiving imatinib, dasatinib or nilotinib in chronic myeloid leukemia: reports collected by the French network pharmacovigilance centers
Arch Gynecol Obstet
.
2017 Apr;295(4):1059.
doi: 10.1007/s00404-017-4321-0.
Authors
Patrick Carlier
1
,
Maritza Markarian
2
,
Nathalie Bernard
3
,
Laurence Lagarce
4
,
Anne Dautriche
5
,
Johanna Béné
6
,
Nathalie Fouilhe Sam-Lai
7
,
Pirayeh Eftekhari
2
Affiliations
1
Centre régional de Pharmacovigilance, Hôpital Fernand-Widal, AP-HP, Paris, France. pharmacovigilance.fwd.lrb@aphp.fr.
2
Centre régional de Pharmacovigilance, Hôpital Fernand-Widal, AP-HP, Paris, France.
3
Centre régional de Pharmacovigilance, Hospices Civils de Lyon, Lyon, France.
4
Centre régional de Pharmacovigilance, CHRU Angers, Angers, France.
5
Centre régional de Pharmacovigilance, CHU Dijon, Dijon, France.
6
Centre régional de Pharmacovigilance du Nord Pas de Calais, CHU Lille, 59000, Lille, France.
7
Centre régional de Pharmacovigilance, CHU Grenoble Alpes, Grenoble, France.
PMID:
28255764
DOI:
10.1007/s00404-017-4321-0
No abstract available
Publication types
Published Erratum